Pharma's Almanac | Cell and Gene Therapy

237 Articles Available

1 10

Viral Vectors

Facing the Dual Scientific and Financial Challenges to Advance Cell and Gene Therapies

PAO-11-23-CL-02

Digitalization, AI, and Automation

Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds

PR-M10-23-05

Cell and Gene Therapy Distribution

Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies

PR-M10-23-03

Cell and Gene Therapy

View from the Top: Cell and Gene Therapy Successes and Promise

Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support

Allogeneic Cell Therapy Logistics

Taking a Page from the HSCT Playbook for Allogeneic Cell Therapy Advancement

PAO-06-23-CL-06

History of Innovation

100 Years Young: How Science, Collaboration, and Innovation are Driving Corning’s Future

PAO-05-23-CL-08

AAV Capsid Engineering

Expanding Patient Access to Gene Therapies through AAV Capsid Engineering

PAO-01-23-CL-02

Cell Therapy

Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles

PAO-01-23-NI-01

CAR-T

Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions

PAO-12-022-CL-04

Viral Vector Manufacturing

Optimizing Transient Transfection for Viral Vector Production

PAO-11-022-NI-09

Viral Vectors

Risk-Based Optimization of Viral Vector Processes Adds Real Value

PAO-09-022-CL-05

Cell and Gene Therapy

State of the Cell and Gene Therapy Market

PAO-10-022-NI-01

CGT Hub

Comparative Study Ranks Philadelphia Region #2 Among 14 Cell and Gene Therapy Hubs

PR-M09-22-07

10-Year Anniversary

TrakCel Celebrates 10 years of Market Leading Cell Orchestration Solutions by Setting out Future Plans

PR-M08-22-04

Cell and Gene Therapy Analytics

Accelerating the Development of High-Quality Cell and Gene Therapies with Comprehensive, In-house Analytical Support

PAO-06-022-CL-07

New Facility

AGC Biologics Invests in Viral Vector Suspension at New U.S. Campus

PR-M05-22-13

Plasmid DNA

Translating Three Decades of Experience in Plasmid DNA Into Customer Success

PAO-05-022-CL-04

Vaccine and Cell & Gene Therapies

Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics

PAO-04-022-CL-02

Cell and Gene Therapy Technology

Advancing Technologies in Cell and Gene Therapy

PAO-04-22-R250-09

Column: M&A

Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game

PAO-03-022-NI-08

Column: Regional

Expanding the Cell and Gene Therapy Ecosystem in Philadelphia

PAO-12-21-CL-05

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

PAO-02-022-CL-14

M&A

Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-High-Throughput Screening Platform

PR-M03-22-05

1 10

Cell and Gene Therapy

237 Articles Available

Can't find what you're looking for? Try our advanced search.

Viral Vectors

Facing the Dual Scientific and Financial Challenges to Advance Cell and Gene Therapies

Digitalization, AI, and Automation

Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds

Cell and Gene Therapy Distribution

Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies

Cell and Gene Therapy

View from the Top: Cell and Gene Therapy Successes and Promise

Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support

Allogeneic Cell Therapy Logistics

Taking a Page from the HSCT Playbook for Allogeneic Cell Therapy Advancement

History of Innovation

100 Years Young: How Science, Collaboration, and Innovation are Driving Corning’s Future

AAV Capsid Engineering

Expanding Patient Access to Gene Therapies through AAV Capsid Engineering

Cell Therapy

Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles

CAR-T

Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions

Viral Vector Manufacturing

Optimizing Transient Transfection for Viral Vector Production

Viral Vectors

Risk-Based Optimization of Viral Vector Processes Adds Real Value

Cell and Gene Therapy

State of the Cell and Gene Therapy Market

CGT Hub

Comparative Study Ranks Philadelphia Region #2 Among 14 Cell and Gene Therapy Hubs

10-Year Anniversary

TrakCel Celebrates 10 years of Market Leading Cell Orchestration Solutions by Setting out Future Plans

Cell and Gene Therapy Analytics

Accelerating the Development of High-Quality Cell and Gene Therapies with Comprehensive, In-house Analytical Support

New Facility

AGC Biologics Invests in Viral Vector Suspension at New U.S. Campus

Plasmid DNA

Translating Three Decades of Experience in Plasmid DNA Into Customer Success

Vaccine and Cell & Gene Therapies

Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics

Cell and Gene Therapy Technology

Advancing Technologies in Cell and Gene Therapy

Column: M&A

Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game

Column: Regional

Expanding the Cell and Gene Therapy Ecosystem in Philadelphia

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

M&A

Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-High-Throughput Screening Platform